Strategic Communications and Marketing News Bureau

Ex-NFL player says Congress should regulate steroids in pro sports

Law student and former NFL tight end Josh Whitman says Congress should regulate steroids in pro sports.

Law student and former NFL tight end Josh Whitman says Congress should regulate steroids in pro sports.

CHAMPAIGN, Ill. – Congress should step in to regulate performance-enhancing drugs in professional sports because players and owners lack incentive to effectively police themselves, former NFL tight end Josh Whitman says.

“Faced with the overwhelming incentives present in modern sports – whether tangible like money or intangible like the competitor’s inner drive – it is both unrealistic and arguably unfair to ask athletes to protect themselves from the innate parts of their own character that we cheer so heartily while they are within the competitive arena,” Whitman wrote in an article published in the January issue of the University of Illinois Law Review.

The goal of those involved in professional sports, Whitman says, is to win – now and at virtually any cost. The financial and social benefits gained from on-field success and the rapidly diminishing time window for athletes to achieve that success contribute to a modern sports culture that emphasizes the ends over the means – victory over integrity, Whitman argues.

Whitman is a third-year law student at the U. of I. He was an Academic All-American at Illinois before graduating in 2001 and moving on to the NFL, where he had a four-year career with the Buffalo Bills, San Diego Chargers, Seattle Seahawks and Miami Dolphins.

For some players, Whitman writes, success becomes all-consuming, clouding their decision-making ability.

“Residual notions of fair play, espoused by youth league coaches and well-meaning parents during the athlete’s formative years, are replaced by the overriding pursuit of the fruits of victory. … For many, performance-enhancing drugs provide a competitive edge that enables them to take another step toward their dreams.

“For others, the motivation is less pure: The fame and fortune accompanying drug-induced athletic success can be irresistible,” Whitman wrote.

Whitman contends steroid use in sports threatens impressionable youth, as well as “many of the ideals this country holds dear: integrity, hard work and the valorous pursuit of victory.”

“At no time in American history has the awe-inspired question ‘How’d they do that?’ following remarkable athletic accomplishments carried such gravity,” Whitman wrote. “If enthusiasm is the mark of the true fan, skepticism has emerged as its constant companion. Today, no sooner do we applaud amazing athletic achievements than do we ponder the means by which they were accomplished.”

Government regulation would guard the integrity of sports and also protect those youth who might turn to steroids to follow their own dreams of glory, Whitman argues.

Faced with such a skewed incentive system, he argues that Congress, which recently launched another round of hearings on steroids in sports, “should remove the onus of developing drug-testing provisions from the individual parties and should itself create drug-management strategies aimed at reducing (steroid) use in American professional sports to a socially desirable level.”

Whitman’s article, “Winning at all Costs: Using Law & Economics to Determine the Proper Role of Government in Regulating the Use of Performance Enhancing Drugs in Professional Sports,” was awarded the U. of I. Law Review’s Best Note Award and was recently nominated by the College of Law for the Burton Award for Legal Achievement, a national legal writing award.

Editor’s note: To contact Josh Whitman, call 217-265-0347; e-mail jwhitman@illinois.edu.



This article was imported from a previous version of the News Bureau website. Please email news@illinois.edu to report missing photos and/or photo credits.

Read Next

Announcements

Wright selected as U. of I.’s vice chancellor for advancement

Dale Wright, currently the interim vice chancellor for advancement at the University of Illinois Urbana-Champaign, will become the permanent vice chancellor for advancement and senior vice president of the University of Illinois Foundation, pending approval by the University of Illinois Board of Trustees. Until approved by the Board of Trustees, his title will be vice […]

Health and Medicine Sara Gerke, the Richard W. & Marie L. Corman Scholar at the University of Illinois Urbana-Champaign and expert in legal issues surrounding cutting-edge medical developments.

New paper urges caution as FDA plans to phase out animal testing in drug development

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of cheaper, safer pharmaceuticals, but such a novel approach needs to be implemented judiciously and with caution.

Humanities Diptych image with the book cover of "Indifferent Cities" and a photo of Angel Garcia.

Illinois English professor explores his lost family history in new poetry collection

CHAMPAIGN, Ill. — Poet Ángel García examines his disrupted family lineage in his new collection of poetry, seeking answers about where he came from and trying to fill the many gaps in his family’s story. “Indifferent Cities” is the second book by García, a University of Illinois Urbana-Champaign English professor. The book was the winner […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010